Skip to content
Pharma Observatory a Scientist.com platform
  • Supplier site
  • Group of sites (click to zoom)

Scientist.com supplier network (site locations)

Research supplier

CORMICA

CORMICA is listed as a mid sized business research supplier in the Scientist.com network, with 7 sites in 3 countries.

View CORMICA on Scientist.com

Sign in to Scientist.com to open this supplier in your organization's marketplace.

Email me this page as a PDF

Search companies, drugs, suppliers and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Sites 7
Countries 3

Services

What this research supplier says it provides, as listed in the Scientist.com network.

Type of company: Mid sized business

Biomarkers

  • Antimicrobial Effectiveness Testing Measure the efficacy of anti-microbial preservatives added to a product.

Cell Culture and Characterization

  • Bacterial Cell Culture Culture and Grow bacterial cells.

Chemical and Compound Analysis

  • Adsorption/Desorption Studies Obtain data on groundwater risk assessment.
  • API Physical Characteristics Characterize physical and chemical properties of new drug molecules to develop safe, effective, and stable dosage forms.
  • Chemical Stability Measure the stability of small molecules in solution.
  • Compound Integrity Analyze the identity and purity of small molecule drug candidates.
  • Differential Scanning Calorimetry Elucidate the thermodynamics associated with conformational transitions.
  • Dissolution Profiling Measure release of API from formulation (tablet or capsules) under GMP guidelines.
Show all 34 in Chemical and Compound Analysis 28 more
  • Dynamic Light Scattering Determine the size of particles and extent of molecular aggregation in a suspension.
  • Elemental Impurity Analysis Identify and evaluate the presence of heavy metals in pharmaceuticals.
  • Endotoxin Testing Use standard assays like LAL (Limulus Amebocyte Lysate), rFC (Recombinant Factor C), or MAT (Monocyte Activation Test) to detect and quantify the level of endotoxins in a sample
  • Excipient Compatibility Test excipients for drug formulation, effects of temperature, time, humidity, pH and light exposure as well as excipient release.
  • Gas Chromatography Gas chromatography is an analytical technique that separates, identifies, and quantifies compounds in a mixture
  • Headspace Gas Chromatography Analyze volatile organic compounds (VOCs) partitioned above the liquid/solid phase of a sample.
  • Heavy Metals Analysis Ensure trace levels of heavy metals are below the maximum allowable limits for consumer safety.
  • Inductively Coupled Plasma (ICP) Analysis Characterize ultra-small levels of multiple solid analytes simultaneously.
  • Inductively Coupled Plasma-Mass Spectrometry (ICP-MS) Analysis Detect metals and several non-metals at concentrations as low as one part in 1015 (part per quadrillion, ppq) on non-interfered low-background isotopes.
  • Ion Exchange Chromatography Separate and detect analytes.
  • Lipid Nanoparticle (LNP) Characterization Lipid nanoparticle (LNP) characterization is the process of comprehensively analyzing the physical and chemical properties of LNPs and their components to understand their structure, quality, and functionality
  • Liquid Chromatography Separate substances using a mobile and stationary phase.
  • MALDI-TOF Analysis Use mass spectrometry technique to analyze compound, biomolecules and large organic molecules.
  • Melting Point Use melting point analysis to characterize compounds based on calorimetry and thermodynamic data.
  • Particle Size Analysis Measure particle size distribution and characterize particle size, porosity and composition.
  • Partition Coefficient Determine lipophilicity (hydrophobicity) of compounds by measuring log P.
  • Photostability Measure drug degradation rates after exposure to various light sources.
  • Physicochemical Analysis Physicochemical Analysis of material or preparation evaluating (e.g.) particle size, composition, or compound structure.
  • Process Residual Impurities Detection Measure trace levels of impurities.
  • Protein Melting Point Analysis Assess protein stability by Differential Scanning Calorimetry (DSC) or Fluorimetry (Thermofluor) methods.
  • Raman Spectroscopy Use spectroscopic technique to observe vibrational, rotational and other low-frequency modes in a system.
  • Scanning and Transmission Electron Microscopy Examine the fine structures of molecules, cells and tissues with sub-nanometer resolution.
  • Size Exclusion Chromatography Separate and identify analytes based on their molecular size.
  • Solid State Nuclear Magnetic Resonance Identify molecular structure or impurities and assess product integrity of solid samples.
  • Solubility Studies Analyze substances for kinetics of solubility using nephelometry and UV-Vis spectrometry.
  • Solution Nuclear Magnetic Resonance Identify molecular structure or impurities and assess product integrity of solution samples.
  • Structural Elucidation Determine chemical structure of a compound. Characterization techniques include mass spectrometry, infrared spectroscopy and X-ray crystallography.
  • Viscosity Testing Evaluate the fluid flow properties of liquids for product evaluation and quality control.

Chemical and Compound Testing

  • Bacterial Water Analysis Analyzing water samples to identify the bacteria present.
  • Limulus Amebocyte Lysate (LAL) Test Detect bacterial endotoxins in raw materials used for the production of cosmetics products.
  • Product Testing Ensure product quality standards are met.
  • USP <2021> Microbial Enumeration Tests Estimate the total aerobic microbial count, total combined yeast and mold counts, and the presence of bile-tolerant gram-negative bacteria present in nutritional supplements.
  • USP <2022> Microbiological Procedures for Absence of Specified Microorganisms Determine the absence of objectionable organisms in nutritional supplements.
  • USP <85> Bacterial Endotoxin Test Test to detect or quantify bacterial endotoxins that may be present in or on a sample.
Show all 161 services 147 more

Chemistry, Manufacturing and Controls (CMC)

  • Analytical Development and Validation Request services related to Analytical Development and Validation
  • API and Drug Product Stability Testing API and Drug Product Stability Testing.
  • API and drug product storage and release API and drug product storage and release
  • API/ Excipients Compatibility Studies Delineate real and possible interactions between potential formulation excipients and the API as an important risk reduction exercise early in formulation development.
  • API/DP specific test methods API/DP specific test methods (e.g., stability indicating HPLC assay and purity)
  • Chemistry, Manufacturing and Controls (CMC) Request Chemistry, Manufacturing and Controls services
Show all 18 in Chemistry, Manufacturing and Controls (CMC) 12 more
  • Compendial test methods Run Compendial test methods (e.g., KF)
  • Crystallization studies Crystallization studies
  • Drug Product Stability Use accelerated stress conditions to determine degradation pathways and identify manufacturing issues.
  • Drug Substance and Drug Product Characterization and Manufacturing Drug Substance and Drug Product Characterization and Manufacturing.
  • Forced Degradation Run light, heat, humidity, acid hydrolysis and oxidation tests to evaluate substance degradation.
  • ICH-compliant stability testing Perform ICH-compliant stability testing
  • Medical Device Manufacturing Prototyping and Short run production
  • Milling, grinding, spray-drying Milling, grinding, spray-drying
  • Polymorph Screening Screen for unwanted API forms resulting from the drug formulation process.
  • Powder Blending Use automatic or semi-automatic powder blending machinery to produce consistent mixes.
  • Salt Form Selection Use high-throughput automated arrays to combine APIs with multiple salts and ions to optimize formulation.
  • Thermal Analysis Characterize compounds based on calorimetry and thermodynamic data.

Clinical Consulting

  • Regulatory Consulting Ensure that each product or device complies with all FDA rules and regulations.

Clinical Trials

  • Central Laboratory Services A centralized facility that handles the processing and analysis of samples collected from multiple sites in a study.
  • Regulatory Affairs Consulting Receive assistance ensuring compliance with regulatory requirements.
  • Regulatory Operations Ensure that all specific regulatory documents are published and properly organized before submission.&nbsp;

Discovery Chemistry

  • Extractable and Leachable Assessment Quantify potential impurities from container closures & packaging.
  • LCMS Analysis Physically separate substances using liquid chromatography and mass spectrometry.
  • Leaching and Aged Leaching Assess the leaching potential of products with studies that follow the formation and movement of metabolites or show restricted leaching under simulated use conditions.
  • Library Design & Evaluation Use structural knowledge to design target-focused compound libraries for screening.
  • Method Development and Validation Develop and validate methods for synthesis and scale up of drug candidates.
  • Trace Elemental Analysis Identify organic and inorganic elements in foods and dietary supplements at ppm to sub-ppt levels.

Disease Models

  • Irritant Models Measure therapeutic endpoints in animal models of skin irritation.
  • Thrombosis Models Measure therapeutic endpoints in animal models of thrombosis.

Drug Development

  • Chemistry, Manufacturing and Controls (CMC) Consulting Consultant services related to the development of pharmaceutical and biopharmaceutical drug products that are consistently effective, safe and high quality for consumers.
  • Consulting Services Work with consultants who provide expert advice in various areas of research and technology.
  • Toxicology Consulting Use models to assess acute and sub-acute toxicity as well as chronic and sub-chronic toxicity.

Food Safety & Regulations

  • Anaerobic Plate Count Determine the total anaerobic bacteria present in a food or contact-surface sample.
  • E.coli 0157 Tests Isolate and identify the presence of a distinct variant of the E.coli species or its potent toxin in food, water or contact-surface samples.
  • E.coli spp. Testing Use molecular, immunological or cultured methods to detect the presence of E.Coli species in samplings from food, water, contact surfaces or another source.
  • Listeria monocytogenes Tests Assess product samples or the direct contact surfaces for a specific and prevalent Listeria species capable of growth at low temperatures.
  • Listeria spp. Testing Use molecular, immunological or cultured methods to identify potential growth sites for all species of the Listeria genus.
  • Norovirus spp. Testing Use molecular, immunological or microscopic methods to detect and quantify Norovirus species in food, water or contact-surface samples.
Show all 11 in Food Safety & Regulations 5 more
  • Pseudomonas aeruginosa Testing Use molecular, immunological or cultured methods to confirm the presence or absence of P.aeruginosa in samples from food, water or processing surfaces.
  • Pseudomonas spp. Testing Detect the presence and abundance of various cold-tolerant Pseudomonas species that cause or contribute to spoilage in meat, poultry, seafood, dairy or beverages.
  • Salmonella spp. Testing Use molecular, immunological or cultured methods to identify the presence of Salmonella species in food or contact-surface samples.
  • Shigella spp. Testing Use molecular, immunological or cultured methods to detect various species of Shigella in food samples.
  • Total Viable Count (TVC) Estimate the total living microbial populations present in a food or beverage sample to guarantee product quality.

General in vivo Toxicology

  • Carcinogenicity Study - Mouse Conduct a repeat dose, chronic carcinogenicity study in mice to determine the tendency of your compound to produce tumors.
  • Carcinogenicity Study - Rat Conduct a repeat dose, chronic carcinogenicity study in rats to determine the tendency of your compound to produce tumors.
  • Effective Dose (ED), 50% Toxicity Test Quantify the diluted toxin needed to induce sub-lethal effects upon constant exposure in half of test organisms.
  • General Toxicology Use in vivo models to assess acute and sub-acute toxicity as well as chronic and sub-chronic toxicity.
  • IV Toxicology Test the toxicological effect of IV delivery of drug candidate.
  • Mammalian Toxicology Use toxicity testing models to carry out required FDA or REACH safety testing.
Show all 16 in General in vivo Toxicology 10 more
  • Oral Toxicology Use toxicity studies in animals to evaluate the oral toxicity of a drug candidate.
  • Repeat Dose Toxicity Study - Dog / Canine Conduct a repeat dose study in dogs to determine the toxicity and toxicokinetic behavior of your compound.
  • Repeat Dose Toxicity Study - Monkey / Non-human Primate Conduct a repeat dose study in monkey/non-human primates to determine the toxicity and toxicokinetic behavior of your compound.
  • Repeat Dose Toxicity Study - Mouse Conduct a repeat dose study in mice to determine the toxicity and toxicokinetic behavior of your compound.
  • Repeat Dose Toxicity Study - Other Species Conduct a repeat dose study in other species to determine the toxicity and toxicokinetic behavior of your compound.
  • Repeat Dose Toxicity Study - Rat Conduct a repeat dose study in rats to determine the toxicity and toxicokinetic behavior of your compound.
  • Short-Term Toxicity Tests Acquire preliminary data about the concentrations, exposure duration and effects of a toxin on organisms.
  • Single Dose Acute Toxicity Study - Dog / Canine Conduct a single dose study in Dogs and Canines to determine the toxicokinetic behavior of your compound.
  • Single Dose Acute Toxicity Study - Monkey / Non-human Primate Conduct a single dose study in Monkeys and Non-human Primates to determine the toxicokinetic behavior of your compound.
  • Single Dose Acute Toxicity Study - Mouse Conduct a single dose study in Mice and Murines to determine the toxicokinetic behavior of your compound.

In Vitro Assays

  • Assay Development Construct or create new assays or modify existing ones.
  • Microbiology Study microbes and their role in human health.

In Vitro Pharmacology

  • In Vitro Hemolysis Assay Evaluate the toxicity of a drug, metabolite or excipient by hemolytic release of hemoglobin in the plasma.

In Vitro Toxicology

  • Cytotoxicity Test for effects on cell viability and proliferation
  • Cytotoxicity Testing Determine whether a cosmetic product or ingredient is toxic to in vitro cell cultures.
  • Genotoxicity Evaluate potential of a compound to cause mutations and chromosomal aberations
  • Toxicology- in vitro Toxicity testing and model development in vitro on developmental and adult neurotoxicity

Market Access

  • Market Access Materials Find general strategies and methods used to market a pharmaceutical product or device.

Medical Communications

  • Medical Devices Biological Evaluation Report Audit Conduct a bio-compatibility evaluation of medical devices within the human body.
  • Medical Standard A specialized governance and compliance function responsible for the final technical and regulatory certification of all scientific materials.
  • Regulatory Submissions and Compliance Draft, format, and submit documents to Pharmaceutical approval agencies according to documentation and guidelines. This includes documents such as NDAs, INDs, SUSARs, AE reporting, RMPs, and PSURS.

Other Specialty Toxicology

  • Microbial Testing Test samples for microorganisms, identify species, do bioburden analysis and measure endotoxin levels (LAL).

Pharmacovigilance

  • Periodic Safety Update Reports (PSURs) / Periodic Benefit-Risk Evaluation Reports (PBRERs) Preparation of safety reports to report adverse events that occurred during a specified time period. Evaluate if safety profile of treatment has changed since last report.
  • Regional Regulatory Consulting Regional regulatory consulting provides expert guidance on local regulatory requirements and processes to help companies navigate and comply with the specific rules and standards of different geographical regions...
  • Risk-Based Monitoring Planning and Implementation Risk-based monitoring planning and implementation involve creating and executing a strategy that prioritizes monitoring resources based on the potential risks to patient safety and data quality in clinical trials...

Processing, Packaging, & Preservation

  • UV Sterilization & Treatment Sterilize food, medical equipment and other materials using ultra-violet light technologies.

Raw Materials

  • Ingredient Delivery Systems Ingredients that aid in the skin penetration of other active ingredients.

REACH Services

  • OECD 402: Acute Dermal Toxicity This method provides information on health hazard likely to arise from short-term exposure to a test chemical by dermal route.
  • OECD 403: Acute Inhalation Toxicity This method provides information on health hazard likely to arise from short-term exposure to a test article (gas, vapour or aerosol/particulate test article) by inhalation.
  • OECD 404: Acute Dermal Irritation/Corrosion This method provides information on health hazard likely to arise from exposure to liquid or solid test substance by dermal application.
  • OECD 405: Acute Eye Irritation/Corrosion This method provides information on health hazard likely to arise from exposure to test substance (liquids, solids and aerosols) by application on the eye.
  • OECD 406: Skin Sensitisation This method provides information on health hazard likely to arise from exposure to test substance via intradermical injection and/or epidermical application.
  • OECD 407: Repeated Dose 28-day Oral Toxicity Study in Rodents This method provides information on health hazard likely to arise from exposure to test substance via oral administration.
Show all 23 in REACH Services 17 more
  • OECD 408: Repeated Dose 90-Day Oral Toxicity Study in Rodents This method provides information on health hazard likely to arise from exposure to test substance via oral administration.
  • OECD 410: Repeated Dose Dermal Toxicity: 21/28-day Study This study relates to the analysis, via dermal application, of the health hazard of solid or liquid test substance.
  • OECD 411: Subchronic Dermal Toxicity: 90-day Study This study relates to the analysis, via dermal application, of the health hazards of solid or liquid test substance.
  • OECD 414: Prenatal Developmental Toxicity Study This Test Guideline for developmental toxicity testing is designed to provide general information concerning the effects of prenatal exposure on the pregnant test animal and on the developing organism.
  • OECD 416: Two-Generation Reproduction Toxicity This Test Guideline for two-generation reproduction testing is designed to provide general information concerning the effects of a test substance on the integrity and performance of the male and female reproductive...
  • OECD 420: Acute Oral Toxicity - Fixed Dose Procedure A principle of the method is that in the main study only moderately toxic doses are used, and the administration of doses that are expected to be lethal should be avoided. This Guideline is intended primarily for use...
  • OECD 421: Reproduction/Developmental Toxicity Screening Test The test substance is administered in graduated doses to several groups of males and females.
  • OECD 423: Acute Oral toxicity - Acute Toxic Class Method The acute toxic class method set out in this Guideline is a stepwise procedure with the use of 3 animals of a single sex per step. Depending on the mortality and/or the moribund status of the animals, on average 2-4...
  • OECD 451: Carcinogenicity Studies The objective of a long-term carcinogenicity study is to observe test animals for a major portion of their life span for the development of neoplastic lesions during or after exposure to various doses of a test...
  • OECD 452: Chronic Toxicity Studies Evaluate the direct and indirect impact of prolonged and repeated toxin exposure to test organisms.
  • OECD 471: Bacterial Reverse Mutation Test (Ames) Measure the mutagenic potential of test compounds.
  • OECD 473: In Vitro Mammalian Chromosomal Aberration Test Assess the ability of the test substance to cause structural chromosomal aberrations in cultured mammalian cells.
  • OECD 474: Mammalian Erythrocyte Micronucleus Test The mammalian in vivo micronucleus test is used for the detection of damage induced by the test substance to the chromosomes or the mitotic apparatus of erythroblasts, by analysis of erythrocytes as sampled in bone...
  • OECD 475: Mammalian Bone Marrow Chromosomal Aberration Test The mammalian in vivo chromosome aberration test is used for the detection of structural chromosome aberrations induced by test compounds in bone marrow cells of animals, usually rodents (rats, mice and Chinese...
  • OECD 476: In Vitro Mammalian Cell Gene Mutation Test (Mouse Lymphoma Assay) Determine if a compound is mutagenic by using cultured mammalian cells.
  • OECD 487: In Vitro Mammalian Cell Micronucleus Test Assess whether a test substance induces chromosomal changes in cultured cells.
  • Pyrogen Test Find suppliers who offer safety tests to detect fever-inducing substances (pyrogens) in pharmaceutical products, medical devices, and other biological products

Regulatory Affairs

  • Period Benefit Risk Evaluation Report (PBRER) Preparation of safety reports to report adverse events that occurred during a specified time period. Evaluate if safety profile of treatment has changed since last report
  • Regulatory Submission Documents Request services related to the submission and writing of New Drug Applications (NDA), Investigational New Drugs (INDs), and Investigator Brochures (IB) to the FDA and other regulatory bodies.
  • Risk Evaluation & Mitigation Strategy (REMS) Evidence required by FDA to support the benefit of treatment outweighs the risks. Purpose of REMS is to prevent, monitor, and manage serious risk by informing, educating, and reinforcing actions to reduce frequency...

Testing Services

  • Accelerated Stability Determine shelf life of drug formulations by comparing API breakdown at elevated temperature.
  • Bacterial Identification Testing Use biochemical and molecular methods to identify unknown microorganisms.
  • Cosmetic Preservative Efficacy Test Assess the efficacy of a product's preservative system.
  • Elevated Temperature Stability Determine the stability of a product at elevated temperature.
  • Freeze-Thaw Testing Use freeze-thaw cycling to measure the long-term durability of cosumer products.
  • In Vitro Toxicology Testing Non-animal testing employing US and international methodologies for determining irritation and other undesirable potentials.
Show all 16 in Testing Services 10 more
  • Microbiological Sterility Testing Test the presence of viable microorganisms.
  • Ocular Irritation Test Use human subjects to determine whether a cosmetic product or ingredient can cause ocular irritation.
  • OECD 428: In Vitro Skin Penetration Request OECD 428 services. This method is designed to provide information on absorption of a test substance, (ideally radiolabelled), applied to the surface of a skin sample separating the two chambers (a donor...
  • OECD 439: Skin Irritation Test (SIT) Reconstructed Human Epidermis Test (RhE) Method - An in vitro testing method designed to identify chemicals and/or mixtures capable of inducing moderate skin irritation.
  • Package Compatibility Tests Ensure that the consumer product is not adversely affected by the package components and vice versa.
  • Raw Material Microbiological Testing Examples of which include Microbial Content using USP <61> and <62> and other standards, LAL Endotoxin, Ames Mutagenicity and Sterility.
  • Real-time Stability Test Assure stability and physical integrity of consumer products in real-time conditions.
  • Safety In-Use Studies Safety-in-use studies assess the potential for a product to elicit adverse reactions under normal use conditions.
  • USP <61> Microbial Limits Test Determine whether a substance or preparation complies with an established specification for microbiological quality.
  • USP <62> Microbial Limits Test Determine the presence or absence of specific microorganisms.

Source: Scientist.com supplier network

Where it operates

Sites by country, with the cities in each.

  • United Kingdom Bradford, Dover, Gosport, London 4 sites
  • United States Allentown, Cherry Hill Township 2 sites
  • Germany Göldern 9 1 site

Source: Scientist.com supplier network (site locations)

About this supplier

In the supplier's own words, as listed in the Scientist.com network.

Professional associations
BioForward
Website
www.cormica.com

Source: Scientist.com supplier network, written by the supplier

Get the CORMICA report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Sources: Scientist.com supplier network.

Work with CORMICA on Scientist.com

For prices, more details, or to contact CORMICA, visit Scientist.com.

Sign in to Scientist.com to open this supplier in your organization's marketplace.